what is micro dose glp 1 GLP-1 microdosing for weight loss safe and effective? Safety Information forProactive HealthMicrodose GLP-1Rx
Description
Delayed gastric emptying is found in 2765% of patients with type 1 diabetes and in up to 30% of patients with type 2 diabetes [29]
Contraindications include a history of pancreatitis or diabetic ketoacidosis, hypoglycemia, and angioedema [81]
I.V., Intravenous
[2] comprehends 2 RCTs in a single publication without overlapping population, met the inclusion criteria, involving a total of 917 patients: 458 in the GLP-1 receptor agonist group and 459 in the placebo or standard treatment group, being 70.53% males and mean age 51.2 years
Despite high upfront costs, economic modeling suggests potential long-term value
